Close
Close
Close

A growing product offering for CNS disorders

Central nervous system (CNS) diseases and conditions affect millions of people globally, from newborn babies to the elderly. Building on a strong knowledge in the therapeutic areas of pain and addiction, Ethypharm is expanding its product portfolio in CNS to better serve the needs of patients and healthcare providers.

We go beyond traditional pain management

Chronic pain is a major public health challenge in the 21st century. The most severe forms of pain are often treated with opioids, but these products have to be prescribed carefully due to their potential addictiveness.

Ethypharm contributes knowledge and information on the latest and best practices regarding the use of opioids. Our aim is to ensure safe and appropriate access to our pain medicines.

Ethypharm

Ethypharm

Helping reduce the risks and damages caused by addiction

Addiction often affects not only the patient but also their families and friends. Substance dependency is a challenging issue in many countries around the world.

Ethypharm is a leader in the treatment of opioid dependency in the United Kingdom and has built close collaborations with leading healthcare organisations and specialist professionals in the care of opioid dependent individuals. Our range of products includes formulations of the three most prescribed molecules in opioid dependency treatment.